Skip to content
Norton & Elaine Sarnoff Center for Jewish Genetics Logo
  • Home
  • Get Screened
  • About Us
    • Board Members
    • Staff
  • Genetic Disorders
    • Types of Genetic Disorders
    • Jewish Genetic Disorder FAQs
    • Rabbinical Insights
  • Hereditary Cancer
    • BRCA Mutations
    • Lynch Syndrome
    • Assess Your Risk
    • Cancer FAQs
    • Cancer Resources
  • Resources
    • Preimplantation Genetic Testing
    • Family Health History
    • Teach Jewish Genetics
    • Community Resources
    • Educational Brochures
    • For Medical Professionals
    • Personal Stories
    • Blog
  • Get Involved
    • Events
    • Donate
Previous Next

HADHA-Related Disorders

HADHA-related disorders occur when the body lacks an enzyme called mitochondrial trifunctional protein, crucial for breaking down specific fats into energy. Without this enzyme, these fats accumulate and damage organs. Mutations in the HADHA gene cause these disorders.

Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency (LCHADD): People with LCHADD struggle to convert long-chain fatty acids into energy, especially when they’re not eating, are sick, or doing intense exercise. Symptoms start in infancy and include weak muscles, low energy, vision loss, seizures, and even heart problems, sometimes leading to coma or death.

Mitochondrial Trifunctional Protein Deficiency (MTPD): MTPD shows similar symptoms to LCHADD, often more severe. Babies with MTPD usually don’t survive infancy. Less severe cases may not show symptoms until fasting or during illness or exercise, potentially leading to brain damage and developmental issues.

Both conditions are managed with special diets, avoiding fasting, and supplements. A low-fat, high-carb diet with frequent meals is essential. Supplements like medium-chain triglyceride oil and L-carnitine might be prescribed for extra energy, especially during illness or stress. Regular medical guidance is crucial for proper management.

This group of conditions is caused by pathogenic (disease-causing) variants in the HADHA gene and exhibits autosomal recessive inheritance. This means that both parents must be carriers to have a 25% chance to have a child with the condition. The risk of being a carrier is based on a person’s ancestry or ethnic background. 

People who are carriers for HADHA-related disorders usually don’t experience symptoms of the disease. However, if a pregnant person carries a fetus affected by HADHA-related disorder, there’s a higher risk of serious complications, especially in the third trimester. These complications may involve conditions like HELLP syndrome and acute fatty liver of pregnancy. It’s important for pregnant people at risk of such disorders to talk to their doctors. They might also find it helpful to consult with a high-risk physician for specialized advice.

Resources:  

Medline Plus (LCHADD)

Medline Plus (MTPD)

Revised October 2023

Scott Weissman2023-10-26T13:54:27+00:00October 26, 2023|

Share This Story, Choose Your Platform!

FacebookXRedditLinkedInWhatsAppTumblrPinterestVkXingEmail

About the Author: Scott Weissman

The Norton & Elaine Sarnoff Center for Jewish Genetics is a supporting foundation of the Jewish United Fund, and is supported in part by the Michael Reese Health Trust.

30 S Wells
Chicago, IL 60606
312-357-4718
jewishgenetics@juf.org

About
  • About Us
  • Genetic Disorders
  • Hereditary Cancer
  • Donate
Resources
  • Medical Professionals
  • Teach Jewish Genetics
  • Events

©2025 Norton & Elaine Sarnoff Center for Jewish Genetics

Page load link
Go to Top